ECS Botanics Holdings Ltd

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:ECSHealthcare
Country Australia
PE (Fwd) •••
TSR 7Y CAGR (30.43%)
Div yield —
ROE (8.40%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.18
PE TTM —
TSR TTM (37.50%)
Mkt cap A$8.005M
ROIC (1.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0058
15.89%
(40.06%)
Sell 0|1|10|10|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
15.49%
20.47%
10.28%
10.04%
Revenue$M
0.964
0.942
0.947
0.972
8.87%
0.75%
2.05%
5.59%
Peers (US$5.498M)
Cap (US$)
PE
5.703M
0.342x
5.345M
148.1x
4.921M
—
Capital
TTM
5Y
10Y
Leveragex
7.788
0.203
0.169
EBIT/Intx
0.456
0.561
0.385
Own earn%
(37.18)
1.86
(1.46)
Sh yield%
31.21
27.21
26.18
Owners
Insiders/Inst%
4.40
57.02
Short interest%
2.55
SBC / revenue%
3.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
13